MENU
+Compare
PSTV
Stock ticker: NASDAQ
AS OF
Feb 4, 04:59 PM (EDT)
Price
$0.24
Change
-$0.00 (-0.00%)
Capitalization
42.9M

PSTV Plus Therapeutics Forecast, Technical & Fundamental Analysis

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases... Show more

PSTV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PSTV with price predictions
Feb 03, 2026

PSTV sees MACD Histogram just turned negative

PSTV saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on January 09, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PSTV as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

PSTV moved below its 50-day moving average on January 09, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PSTV crossed bearishly below the 50-day moving average on December 30, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The 50-day moving average for PSTV moved below the 200-day moving average on January 29, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PSTV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PSTV entered a downward trend on January 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PSTV advanced for three days, in of 240 cases, the price rose further within the following month. The odds of a continued upward trend are .

PSTV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.489) is normal, around the industry mean (27.519). P/E Ratio (0.000) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (331.843).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PSTV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PSTV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PSTV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a late stage cell therapy company, which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4200 Marathon Boulevard
Phone
+1 737 255-7194
Employees
20
Web
https://www.plustherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AKBTY4.24N/A
N/A
Akbank Turk Anonim Sirketi
EDCFF0.20N/A
N/A
ENEL GENERACION COSTANERA S A
MNQFF16.17N/A
N/A
Manulife Financial Corp.
CSIOY98.95-1.05
-1.05%
Casio Computer Co., Ltd.
MCHT6.90-0.09
-1.29%
Mauch Chunk Trust Financial Corp.

PSTV and Stocks

Correlation & Price change

A.I.dvisor tells us that PSTV and DRUG have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PSTV and DRUG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PSTV
1D Price
Change %
PSTV100%
-0.62%
DRUG - PSTV
33%
Poorly correlated
-3.12%
PBIGF - PSTV
29%
Poorly correlated
N/A
ZYME - PSTV
28%
Poorly correlated
+1.17%
ARRY - PSTV
27%
Poorly correlated
+1.71%
CRIS - PSTV
26%
Poorly correlated
-0.11%
More